MIRA
INFORM REPORT
|
Report Date : |
21.02.2012 |
IDENTIFICATION DETAILS
|
Name : |
GOPAKUMAR NAIR ASSOCIATES |
|
|
|
|
Registered
Office : |
Shivmangal, 3rd Floor, Near Big Bazaar, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2011 |
|
|
|
|
Year of
Establishment : |
2002 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs.47.512 Millions |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAAPN9727H |
|
|
|
|
Legal Form : |
Sole Proprietory Concern |
|
|
|
|
Line of Business
: |
Concern engaged in Management Consultancy Services, Intellectual
Property Patent Services |
|
|
|
|
No. of Employees
: |
20 (Approximately) (In Office 17 + In Branch 3) |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (51) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established and reputed proprietory concern having
satisfactory track. Proprietor is reported to be an experienced respectable and
resourceful businessman. Dr. Gopakumar G. Nair has 40 Years experienced in
Pharmaceutical and Chemical Industry as Director, Chairman and Managing
Director. Trade relations are reported as fair. Business is active. Payments
are reported to be usually correct and as per commitments. The concern can be considered normal for business dealings at usual
trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INFORMATION PARTED BY
|
Name : |
Dr. Gopakumar G. Nair |
|
Designation : |
Proprietor |
|
Contact No.: |
91-9821152272 |
|
Date : |
18.02.2012 |
LOCATIONS
|
Registered Office : |
Shivmangal, 3rd Floor, Near Big Bazaar, |
|
Tel. No.: |
91-22-40895454 / 28872058 / 28850805 / 32926169 / 32926170 |
|
Mobile No.: |
91-9821152272 (Dr. Gopakumar G. Nair) |
|
Fax No.: |
91-22-28462455 |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
1150 Sq. Ft. |
|
Location : |
Rented |
|
|
|
|
Branch Office : |
#11/23, 2nd Floor, 8th |
|
Location : |
Rented |
SOLE PROPRIETOR
|
Name : |
Dr. Gopakumar G. Nair |
|
Designation : |
Proprietor |
|
Address : |
C-002/003, |
|
Date of Birth/Age : |
11.06.1941 |
|
Qualification : |
|
|
Experience : |
40 Years |
|
Experience |
40 years experience in Pharmaceutical and
Chemical Industry as Director, Chairman and Managing Director with wide range
of experience and expertise in all areas of Pharmaceutical Industry including
related and allied fields. |
|
Export Promotion and Other International Areas |
Ex-Chairman, Pharma Panel (Panel 1) of CHEMEXCIL (Export Promotion Council) Dr. Nair represented Indian Chemical
Industry at the j1thi World Chemical Session (Tripartite Conference) at the
I.L.O. (Int’l. Labor Organization) in As a WHO (NORA funded) expert team member of
study of export of potential of Indian Phytochemicals, Dr. Nair has visited
US, Europe and committees |
|
IPR Advisor/Consultant |
PHARMEXCIL (Pharmaceuticals Export Promotion
Council) for last 3 years. |
|
Lectures, Seminars, workshops and Conferences |
Conducted Indian and Global Conferences
(Global Bio Pharma Conference 2004) and given hundreds of lectures and
speeches at various seminars, workshops and conferences. |
|
Publications |
Dr. Nair is author of large number of Scientific,
Technical Research and popular publications. |
|
Inventor |
Dr. Nair is co-inventor of currently valid
Patent No.1N188860 titled “Novel process for the preparation of 3’
Chloropropiophenone” presently assigned to Sequent Scietific Limited. |
Designation, name
and address of Present Positions held
|
Sr. No. |
Designation |
Name and Address
of Company |
|
1 |
CEO, Principal
Patent Attorney |
Gopakumar Nair Associates |
|
2 |
CEO |
GNA Patent Gurukul, Mumbai |
|
3 |
CMD |
GNANLex Hermeneutics
Private Limited, Mumbai KPO/LPO |
|
4 |
Scientific
Advisor |
Intellectual
Property Industrial
Policy and Promotion, Ministry of Commerce and Industry |
|
5 |
Faculty |
National Institute of Intellectual Property Management,
Ministry of Commerce and Industry (NIIPM), Department of Industrial Policy
and Promotion, CGO complex, C Block, Seminary Hills, |
|
6 |
Ex-Dean |
|
|
7 |
Past President |
IDMA (Indian
Drug Manufacturers’ Association), All |
|
8 |
Ex-Advisor |
BDMA (Bulk Drug
Manufacturers Association), |
|
9 |
President |
1) Bharat Education Society, 2) 3) 4) |
|
10 |
Asst. Editor |
Indian Drugs Indian Drug
Manufacturers’ Association, Mumbai. |
|
11 |
Asst. Editor |
IDMA Bulletin Indian Drug
Manufacturers’ Association, Mumbai. |
|
12 |
Editorial Board
Member |
Indian Express’s
Express Pharma Pulse Mumbai. |
|
13 |
Editorial Board
Member |
Phrmabiz
Chronicle and Pharmabiz. Corn Ipharma
India Private Limited Mumbai. |
|
14 |
Advisory
Committee Member |
Nw Media Communication
Private Limited and Pharmaque st. biz, Biopharmalife (Mecorp Media and Events
Private Limited) |
|
15 |
Past President |
Karthika Nair
Memorial Rehabilitation Centre for Disabled and Handicapped, Vallamkulam,
Thiruvalla Kerala — 689541 |
|
16 |
Special Invitee |
CII National
Committee of Intellectual Property (IP) Owners (2007-08) |
|
17 |
Scientific
Advisory Committee |
Tea Research
Association (TOCKLAI) |
|
18 |
Past President |
Karthika Nair
Smarak Samithi (Charitable Trust), Mumbai and Rehabilitation Centre for
Handicapped. |
|
19 |
Past Chairman
and Managing Director |
Bombay Drugs and
Pharmas Limited (35 years) |
|
20 |
Past Chairman |
BDH Industries
Limited (40 yrs) |
|
21 |
Independent
Director (Listed Companies) |
1) Ultramarine and Pigments Limited 2) Nandan Biomatrix Limited 3) Glochem Industries Limited 4) Sequent Scientific Limited |
|
22 |
Advisor /
Consultant (IPR) |
1) Pharmaceuticals Export Promotion Council (Pharmexcil) 2) National Chemical Labs., Pune (CSIR) 3) Nandan Biomatrix Limited, 4) Laila Impex, Vijaywada 5) Ipca Laboratories Limited 6) Strides Arcolab Limited, 7) Ind-Swift Labs. Limited, 8) Glochem Industries Limited, 9) Calyx Chemicals and Pharmaceuticals Limited (Ex.) 10) FDC Limited 11) DIL Limited 12) NAARM ( And Others |
|
23 |
Websites |
BUSINESS DETAILS
|
Line of Business : |
Concern engaged in Management Consultancy Services, Intellectual Property
Patent Services |
|
|
|
|
Services : |
·
Intellectual Property Management Development
Programme ·
Patent Filing and Prosecution ·
Patent Search Services ·
Freedom to Operate ·
Patent Watch ·
Patent Mining and R and D Coordination ·
Patent Specification and Claims Drafting ·
Patent Expiry Status Report (Worldwide) ·
Pre-Grant and Post-Grant Opposition ·
Patentability Consultancy ·
Trademarks, Copyright and Designs ·
IP Audit and IP Portfolio Creation and
Maintenance ·
Indian Patents Database |
|
|
|
|
Exports : |
|
|
Services : |
Intellectual Property Service |
|
Countries : |
10 Countries |
|
|
|
|
Imports : |
|
|
Services : |
Intellectual Property Service |
|
Countries : |
44 Countries |
|
|
|
|
Terms : |
|
|
Selling : |
Cash |
|
|
|
|
Purchasing : |
Cash |
GENERAL INFORMATION
|
Customers : |
Patent and Trade Mark Inventors and Applicants, Overseas Attorneys |
|
|
|
|
No. of Employees : |
20 (Approximately) (In Office 17 + In Branch 3) |
|
|
|
|
Bankers : |
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
V. D. Shah and Company Chartered Accountants |
|
Address : |
8A, 1st Floor, |
|
Tel. No.: |
91-22-28998537 |
|
Fax No.: |
91-9867150979 |
|
E-Mail : |
|
|
|
|
|
Sister Concern : |
Gnanlex Hermeneutics Private Limited Address: Shivmangal, 3rd
Floor, Near Big Bazaar, Line of
Business: Intellectual Property Service GNA Patent Gurukul Address: Shivmangal, 3rd
Floor, Near Big Bazaar, Line of
Business: Training in field Patent |
CAPITAL STRUCTURE
As on 31.03.2011
|
Capital Investment : |
|
|
Owned : |
Rs.47.512 Millions |
|
Borrowed : |
|
|
Total : |
Rs.47.512
Millions |
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
47.512 |
38.873 |
35.525 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
0.000 |
0.000 |
0.000 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
47.512 |
38.873 |
35.525 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
1.390 |
0.000 |
0.258 |
|
|
2] Unsecured Loans |
0.000 |
0.000 |
0.000 |
|
|
TOTAL BORROWING |
1.390 |
0.000 |
0.258 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
48.902 |
38.873 |
35.783 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
11.794 |
8.675 |
3.476 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
23.407 |
18.596 |
16.565 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
0.000
|
0.000 |
0.000 |
|
|
Sundry Debtors |
3.860
|
4.552 |
3.441 |
|
|
Cash & Bank Balances |
3.777
|
3.037 |
3.671 |
|
|
Other Current Assets |
0.000
|
0.000 |
0.000 |
|
|
Loans & Advances |
6.541
|
4.675 |
9.062 |
|
Total
Current Assets |
14.178
|
12.264 |
16.174 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
0.477
|
|
|
|
|
Other Current Liabilities |
|
|
|
|
|
Provisions |
|
|
|
|
Total
Current Liabilities |
0.477
|
0.662 |
0.432 |
|
|
Net Current Assets |
13.701
|
11.602 |
15.742 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
48.902 |
38.873 |
35.783 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
12.005 |
11.158 |
10.013 |
|
|
|
Reimbursement of Expenses |
0.814 |
0.952 |
0.889 |
|
|
|
Other Income |
6.231 |
1.115 |
1.116 |
|
|
|
TOTAL |
19.050 |
13.225 |
12.018 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Salary to Staff |
5.158 |
4.052 |
3.235 |
|
|
|
Business Promotion |
0.240 |
0.076 |
0.104 |
|
|
|
Advertisement Expenses |
0.227 |
0.045 |
0.026 |
|
|
|
Traveling (Domestic) Expenses |
0.355 |
0.467 |
0.592 |
|
|
|
Traveling (foreign) Expenses |
0.430 |
0.089 |
0.147 |
|
|
|
Legal and Professional Fees |
0.360 |
0.333 |
0.083 |
|
|
|
Printing and Stationery |
0.267 |
0.216 |
0.189 |
|
|
|
Office Expenses |
0.142 |
0.127 |
0.074 |
|
|
|
Other Expenses |
2.214 |
1.827 |
2.290 |
|
|
|
TOTAL |
9.393 |
7.232 |
6.740 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION |
9.657 |
5.993 |
5.278 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
0.012 |
0.021 |
0.012 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION |
9.645 |
5.972 |
5.266 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
0.969 |
0.527 |
0.587 |
|
|
|
|
|
|
|
|
|
|
NET PROFIT |
8.676 |
5.445 |
4.679 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
PAT / Total Income |
(%) |
45.54
|
41.17 |
38.93 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
72.27
|
48.80 |
46.73 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
33.41
|
26.00 |
23.81 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.18
|
0.14 |
0.13 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
0.04
|
0.02 |
0.02 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
29.72
|
18.53 |
37.44 |
LOCAL AGENCY FURTHER INFORMATION
Trade References:
· W. P. Thompson and
Company,
· Blank
· Law Office of
Albert Wai – Kit Chan, LLC (
Website Details:
Brief Bio data (Dr. Gopakumar G. Nair)
40 years in Pharma Industry as Director,
Managing Director and Chairman of various public limited pharma companies, Dr.
Nair has also served Industry Associations for more than 25 years in various
capacities, latest as President of Indian Drug Manufacturers’ Association
(IDMA), during 1999-2000. Presently Dr. Nair is Consultant to Pharmexcil on IPR
and was also a Consultant to NAARM (ICAR) on P.G. Diploma in Intellectual
Property and Technology Management in Agriculture. He was also Advisor to Bulk
Drug Manufacturers’ Association (BDMA) and is currently Advisor/Consultant to
nearly 15 Pharma/Biotech/Agrotech companies. Dr. Nair is also Editor, Assistant
Editor, Editorial Board Member of various publications and journals, relating
to pharma, biotech and chemicals.
In the field of Intellectual Properties,
Dr.Nair was the Dean of Institute of Intellectual Property Studies (TIPS) at
Dr. Nair is a Ph.D from National Chemical
Laboratory (NCL), Pune and has Diploma in Management and Patent Law. Dr. Nair
is also a Law (LL.B) graduate from
He is also associated with various Educational
Institutions such as President, Bharat Education Society, with schools and
colleges under its ambit.
Write-Up — Gopakumar Nair Associates
GNAs® is a premier intellectual property
consultancy and legal advisory firm providing high-quality legal and technical
solutions for companies in the biotechnology, biomedical, chemical, health
care, pharmaceutical, and other knowledge based industries.
Founded by Dr. Gopakumar G. Nair, GNAs®
provides support to wide range of companies for filing patents, domestic and
internationally, as well as help start-up companies using technology licenses from
universities and other research centers.
They also help their clients to identify and
seize opportunities as well as diffuse threats to their intellectual
prosperity.
Though GNAs® is an eight year old intellectual
property firm, they have unrivalled ability and experience over established
firms especially since they are at the right place at the right time and grown
amidst the fast changing IP/Patent scenario in India.
GNAs ® is a premier intellectual property
consultancy and legal advisory firm providing high-quality legal and technical
solutions for companies in the biotechnology, biomedical, chemical, health
care, pharmaceutical, and other knowledge based industries. Founded by Dr.
Goakumar G. Nair, their firm provides support to wide range of companies for
filing patents, domestic and internationally, as well as help start-up
companies using technology licenses from universities and other research
centers. They also help their clients to identify and seize opportunities as
well as diffuse threats to their intellectual prosperity. Though GNAs® is an
eight year old intellectual property firm, they have unrivalled ability and
experience over established firms especially since they are at the right place
at the right time and grown amidst the fast changing IP/Patent scenario in
India.
Nearly four decades of industrial experience
of Dr. Nair at CEO level, has contributed substantially to the success of GNA.
During the latter part of this period, and as office bearer and Past President
of IDMA, Dr. Nair had immense exposure to Uruguay Round related discussions
debates on Dunkel Draft (including with Dr. Arthur Dunkel), WTO and TRIPs
issues including with US Trade Representatives like Ms. Carla Hills and Mr.
Mickey Cantor, Dr. Arthur Dunkell himself and others.
Over the short span of time, they have been
transforming ourselves continuously and considerably, going well beyond their
original strengths. They are also committed to expand their consulting
capabilities and can now deliver services, par excellence, on global platform.
GNAs ® handles Intellectual Property matters
on assignment basis as well as on retainership basis. They maintain high level
of confidentiality in their work as well as with their client relationships.
Their vibrant team is fully geared to protect client- confidentiality.
The blossoming future of Intellectual Property
will be dynamic and even more challenging especially for those valuing
intellectual assets and competing in the global marketplace. They are committed
to apply their consulting and analytical intelligence in providing solutions to
their clients challenging needs, problems and issues.
GNAs® offers peerless solutions to clients in
the areas of intellectual property protection and enforcement. Their
experienced expert Senior Patent and Trademark Associates provide support to
clients in many of the technical aspects of IP, TM and Patent practice. Their
services include:
Intellectual Property Management Development Programme
Intellectual Property Management Development
Programme held in corporate campus by Experts of IP/Patents, Trade Marks, and
Copyright Professionals.
Patent Filing and Prosecution
GNAs provides patent filing, both national and
international (PCT) applications, services to clients, preparing prosecution
templates, replying office actions and sending reminders of upcoming due dates.
GNA5 currently handles filing of patents for a dozen of corporate and law firms
across the country.
Patent Watch Services
GNAs provides customized world-wide Patent Watch
or surveillance services for individual Patents / Patent Applications or field
as a whole, including infringement—related surveillance.
Freedom to Operate
GNA offers Freedom to Operate opinion and
advice on product or technology clearance, thus evading off potential
infringement.
Patent Search
GNAs conducts patent search for clients to
ascertain the novelty of their inventions. Patent search is done by highly
qualified patent associates of GNAs who are skilled in the usage of several online
patent databases. They have in-house access to subscribed patent databases.
Patent Mining and R and D Coordination
GNAs provide patent mining services for R and
D coordination to their corporate clients. They help clients to protect their
interest from the early stages of their project and provide all the required
information before filing the patent application.
Patent Specification and Claims Drafting
GNAs is specialist in patent specification and
claims drafting. They draft patent specifications in accordance to national law
and PCT. Their firm specializes in the more complex and difficult drafts rather
than the routines.
Patent Expiry Status Report Worldwide
GNAs provides patent expiry status report to
clients to determine whether a given patent is still alive or abandoned or has
expired in a specific country.
Pre-Grant and Post-Grant Opposition
GNAs is specialist in drafting and filing
Pre-Grant and Post Grant Oppositions.
Patentability Consultancy
GNA5 offers patentability consultancy to assist
clients in ascertaining the patentability requirement of their inventions. They
help clients in identifying all the three criteria of patentability.
Trademarks, Copyright and Designs
GNA5 offer trademarks, copyright and designs
filing, prosecution, maintenance and enforcement services.
IP Audit and IP Portfolio Creation and Maintenance
GNAs offers IP Audit and IP portfolio services
to corporate clients. Tailor-made IP solutions.
Patent Gurukul
GNA has sponsored Patent Gurukul for creating
Patent Awareness and Patent Proficiency among students and professionals in
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals have
been formally charged or convicted by a competent governmental authority for
any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.49.08 |
|
|
1 |
Rs.77.80 |
|
Euro |
1 |
Rs.65.17 |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
6 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
6 |
|
--LEVERAGE |
1~10 |
6 |
|
--RESERVES |
1~10 |
6 |
|
--CREDIT LINES |
1~10 |
6 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
NO |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
51 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.